The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, signaling significant operational and profitability concerns. Despite a low P/E of 4.72 and a Graham Number of $38.17 suggesting undervaluation, the negative forward P/E, erratic earnings, and extremely high reported profit margin of 1614% indicate unreliable profitability metrics. The stock trades well below analyst target of $55.33, but weak revenue growth, negative operating margins, and bearish insider activity raise sustainability concerns. Technical trend at 0/100 and declining long-term price performance further support a cautious outlook.